Atrial fibrillation and chronic total occlusion percutaneous coronary intervention outcomes: insights from the

Michaella Alexandrou1, Athanasios Rempakos1, Spyridon Kostantinis1

  • 1Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

PubMed

Insights

Atrial fibrillation patients undergoing chronic total occlusion PCI have more complex cases and longer procedures. While in-hospital outcomes are similar, follow-up MACE is higher but not independently linked to atrial fibrillation.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Electrophysiology

Background:

  • Atrial fibrillation (AF) is a common arrhythmia impacting cardiovascular health.
  • Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is a complex procedure.
  • The influence of AF on CTO PCI outcomes requires detailed investigation.

Purpose of the Study:

  • To evaluate the impact of atrial fibrillation on the outcomes of chronic total occlusion percutaneous coronary intervention.
  • To compare baseline characteristics, procedural results, and follow-up events between patients with and without atrial fibrillation undergoing CTO PCI.

Main Methods:

  • A retrospective analysis of 9,166 CTO PCIs from 39 centers (2012-2023).
  • Comparison of patient demographics, comorbidities, lesion characteristics, and procedural data.
  • Assessment of in-hospital and follow-up Major Adverse Cardiovascular Events (MACE), including mortality.

Main Results:

  • 12% of patients had atrial fibrillation; they were older with more comorbidities and complex CTO lesions.
  • Patients with AF experienced longer procedure and fluoroscopy times.
  • Technical success and in-hospital MACE were similar; however, crude follow-up MACE was higher in AF patients.

Conclusions:

  • Atrial fibrillation patients undergoing CTO PCI present with higher complexity and longer procedural times.
  • Despite similar in-hospital outcomes, AF patients show higher crude follow-up MACE.
  • AF was not an independent predictor of adverse events on multivariate analysis.
Abstract